Brief: Alimera Announces Reimbursement Of Uveitis Indication Granted For Iluvien In Ireland
20/09/2022 13:58
Sept 20 (Reuters) - Alimera Sciences Inc ALIM.O :
* ALIMERA ANNOUNCES REIMBURSEMENT OF UVEITIS INDICATION
GRANTED
FOR ILUVIEN® IN IRELAND
Source text for Eikon: ID:nGNX1xjnQ2
Further company coverage: ALIM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alimera Sciences
See all newsBrief: ANI Pharmaceuticals And Alimera Sciences Announce Closing Date Of Merger
Brief: Ani Pharmaceuticals Provides Update On Closing Of Acquisition Of Alimera Sciences
U.S. STOCKS ON THE MOVE-JPMorgan, automakers, energy firms
U.S. STOCKS ON THE MOVE-Arrowhead Pharma, Boeing, Centessa Pharma
Brief: Alimera Sciences Files Lawsuit To Compel ANI To Close Merger